BioSpace News Archive

BioForest

mytaptrack® Named “2019 Classroom Tech Solution of the Year” by EdTech Breakthrough Awards

EdTech Breakthrough recognizes outstanding educational technology products and companies

June 12, 2019
·
3 min read
Business

Blue Cross Blue Shield of Massachusetts Expedites Access to Care for Members Affected by Severe Weather in Arkansas and Oklahoma

In response to recent severe storms, winds, and flooding, Blue Cross Blue Shield of Massachusetts (BCBSMA), Inc. is expediting access to care for members who live in affected areas of Arkansas and Oklahoma.

June 12, 2019
·
1 min read
BioMidwest

CANVIVA™ Introduces Largest Line of CBD Functional Tinctures

C4Life, Inc. of Minnetonka announces the release of a new line of cannabidiol (CBD) products called CANVIVA™.

June 12, 2019
·
3 min read
Job Trends

ClinOne and Virtual Clinical Trials: A Natural Fit

Clinical trials are crucial for new product and device development and are required by the Food and Drug Administration (FDA) before approvals can be granted for their use in the general population.

June 12, 2019
·
2 min read
Job Trends

EarthxOcean Highlights Plight of World Oceans

Global Leaders, Champions from the United Nations and Ocean Activists Raise Profile of Marine Conservation

June 12, 2019
·
4 min read
Policy

Statement from the Government of Canada on the Final Report from the Advisory Council on the Implementation of National Pharmacare

The Honourable Ginette Petitpas Taylor, Minister of Health, tabled in Parliament the final report from the Advisory Council on the Implementation of National Pharmacare.

June 12, 2019
·
1 min read
Business

Jackson Nurse Professionals and Jackson Therapy Partners Open Innovative On-Site Health Center

Companies Partner with CareHere to Open an eHealth™ Center that Utilizes an On-Site Nurse and Secure Video Connection to Provide Care

June 12, 2019
·
5 min read
Deals

Issue and Repurchase of Class C Shares

Orexo AB announces that the company has resolved to issue and immediately thereafter repurchase 63,000 class C shares.

June 12, 2019
·
2 min read
Genetown

$3 million+ medical claims rose 104% from 2015 to 2018

Patients with $1.5 million or more in claims also more than doubled

June 12, 2019
·
4 min read
Drug Development

Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)

Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced top line data from IMPALA, a pivotal Phase 3 clinical study evaluating Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), for the treatment of aPAP.

June 12, 2019
·
10 min read